CP and skin atrophy: Inhibitors of p38, ERK, and JNK were shown to reverse the inhibitory effect of LY treatment mediated by p38 in a dose-dependent manner under CP exposure (Fig. 3D, Fig. 5B), indicating that LY inhibited GC-induced skin atrophy through p38 activation (Fig. 5).